How could I treat?: THE INVITED EXPERT'S OPINIONVRANCKX, Pascal.EuroIntervention. 2011, Vol 7, Num 5, pp 640-641, issn 1774-024X, 2 p.Article

Looking back into the future: desirudin in acute coronary syndromes and coronary stentingVRANCKX, Pascal; VALGIMIGLI, Marco; SERRUYS, Patrick et al.EuroIntervention. 2011, Vol 7, Num 2, pp 263-269, issn 1774-024X, 7 p.Article

HBOC-201 : The multi-purpose oxygen therapeuticDUBE, Gregory P; VRANCKX, Pascal; GERSON GREENBURG, A et al.EuroIntervention. 2008, Vol 4, Num 1, pp 161-165, issn 1774-024X, 5 p.Article

Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study populationVRANCKX, Pascal; MCFADDEN, Eugene; MEHRAN, Roxana et al.EuroIntervention. 2012, Vol 8, Num 3, pp 368-374, issn 1774-024X, 7 p.Article

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity: Addendum to the historical MI definitions used in stent studiesVRANCKX, Pascal; CUTLIP, Donald E; MEHRAN, Roxana et al.EuroIntervention. 2010, Vol 5, Num 7, pp 871-874, issn 1774-024X, 4 p.Article

Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol DesignVALGIMIGLI, Marco; CAMPO, Gianluca; REPETTO, Alessandra et al.Cardiovascular drugs and therapy. 2008, Vol 22, Num 4, pp 313-320, issn 0920-3206, 8 p.Article

Clinical end points in coronary stent trials : A case for standardized definitionsCUTLIP, Donald E; WINDECKER, Stephan; MCFADDEN, Eugene et al.Circulation (New York, N.Y.). 2007, Vol 115, Num 17, pp 2344-2351, issn 0009-7322, 8 p.Article

Assisted circulation using the Tandemheart^®, percutaneous transseptal left ventricular assist device, during percutaneous aortic valve implantation: the Rotterdam experienceVRANCKX, Pascal; OTTEN, Amber; SCHUTLZ, Carl et al.EuroIntervention. 2009, Vol 5, Num 4, pp 465-469, issn 1774-024X, 5 p.Article

Neuromuscular electrical stimulation increases muscle protein synthesis in elderly type 2 diabetic menWALL, Benjamin T; DIRKS, Marlou L; VERDIJK, Lex B et al.American journal of physiology. Endocrinology and metabolism. 2012, Vol 66, Num 3, issn 0193-1849, E614-E623Article

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus documentKAPPETEIN, A. Pieter; HEAD, Stuart J; HAHN, Rebecca T et al.EuroIntervention. 2012, Vol 8, Num 7, pp 782-795, issn 1774-024X, 14 p.Article

Use of impella Recover® LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findingsVALGIMIGLI, Marco; STEENDIJK, Paul; DE JAEGERE, Peter et al.EuroIntervention. 2006, Vol 2, Num 1, pp 91-100, issn 1774-024X, 10 p.Article

Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia)CAMPO, Gianluca; TEBALDI, Matteo; VRANCKX, Pascal et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 6, pp 506-512, issn 0735-1097, 7 p.Article

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trialSILBER, Sigmund; WINDECKER, Stephan; VRANCKX, Pascal et al.Lancet (British edition). 2011, Vol 377, Num 9773, pp 1241-1247, issn 0140-6736, 7 p.Article

Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation: The Valve Academic Research Consortium-2 Consensus DocumentKAPPETEIN, A. Pieter; HEAD, Stuart J; HAHN, Rebecca T et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 15, pp 1438-1454, issn 0735-1097, 17 p.Article

5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery LesionsSERRUYS, Patrick W; ONUMA, Yoshinobu; HAMM, Christian et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 11, pp 1093-1101, issn 0735-1097, 9 p.Article

Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel StudyVALGIMIGLI, Marco; CAMPO, Gianluca; COLANGELO, Salvatore et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 25, pp 3215-3222, issn 0009-7322, 8 p.Article

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions : a lighthouse and as a toe in the waterVRANCKX, Pascal; KINT, Peter-Paul; MOREL, Marie-Angele et al.EuroIntervention. 2008, Vol 4, issn 1774-024X, C39-C44, SUPCArticle

Usefulness of percutaneous left ventricular assistance to support high-risk percutaneous coronary interventionsLEMOS, Pedro A; CUMMINS, Paul; LEE, Chi-Hang et al.The American journal of cardiology. 2003, Vol 91, Num 4, pp 479-481, issn 0002-9149, 3 p.Article

4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents: A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)TANIWAKI, Masanori; STEFANINI, Giulio G; SILBER, Sigmund et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 16, pp 1617-1625, issn 0735-1097, 9 p.Article

Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research ConsortiumMEHRAN, Roxana; RAO, Sunil V; SEREBRUANY, Victor et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 23, pp 2736-2747, issn 0009-7322, 12 p.Article

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumLEON, Martin B; PIAZZA, Nicoto; MOREL, Marie-Angèle et al.European heart journal. 2011, Vol 32, Num 2, pp 205-217, issn 0195-668X, 13 p.Article

Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CADSERRUYS, Patrick W; VRANCKX, Pascal; SYMONS, Janette et al.EuroIntervention. 2008, Vol 3, Num 5, pp 600-609, issn 1774-024X, 10 p.Article

Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: Design and rationale for the MULTI-STRATEGY trialVALGIMIGLI, Marco; BOLOGNESE, Leonardo; HAMON, Martial et al.The American heart journal. 2007, Vol 154, Num 1, pp 39-45, issn 0002-8703, 7 p.Article

Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation A substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) TrialFAROOQ, Vasim; SERRUYS, Patrick W; COLOMBO, Antonio et al.International journal of cardiology. 2013, Vol 168, Num 6, pp 5287-5292, issn 0167-5273, 6 p.Article

Coronary Pressure-Derived Fractional Flow Reserve Measurements: Recommendations for Standardization, Recording, and Reporting as a Core Laboratory Technique. Proposals for Integration in Clinical TrialsVRANCKX, Pascal; CUTLIP, Donald E; MCFADDEN, Eugene P et al.Circulation. Cardiovascular interventions. 2012, Vol 5, Num 2, pp 312-317, issn 1941-7640, 6 p.Article